Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The role of complement in inflammatory diseases from behind the scenes into the spotlight.
Nogo Receptor Inhibition Enhances Functional Recovery following Lysolecithin-Induced Demyelination in Mouse Optic Chiasm.
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
Validation of the PASAT in Argentina.
Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Associated Inosine to interferon: results of a clinical trial in multiple sclerosis.
Molecular mimicry as a mechanism for food immune reactivities and autoimmunity.
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).
Upper limb functional electrical stimulation devices and their man-machine interfaces.
Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.
Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances.
S1P1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity.
The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6.
What is the true clinicopathologic spectrum of neuromyelitis optica?
Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study.
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Virus-induced CD8+ T cells accelerate the onset of experimental autoimmune encephalomyelitis: Implications for how viral infections might trigger multiple sclerosis exacerbations.
Bilateral hypogeusia caused by a small lesion in the lower midbrain tegmentum.
Pathophysiology of immune-mediated demyelinating neuropathies - Part II: Neurology.
Hydration status substantially affects chronic cerebrospinal venous insufficiency assessments.
Characterizations of reflex and nonreflex changes in spastic multiple sclerosis.
Vital role of specialist MS nurses recognised in proposed guideline.
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
Pages
« first
‹ previous
…
386
387
388
389
390
391
392
393
394
…
next ›
last »